Karantas ID - Search Results

1

Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?

Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Siafaka PI, et al. Among authors: karantas id. Pharmaceutics. 2022 Nov 10;14(11):2425. doi: 10.3390/pharmaceutics14112425. Pharmaceutics. 2022. PMID: 36365243 Free PMC article. Review.

2

Porous dressings of modified chitosan with poly(2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin.

Siafaka PI, Zisi AP, Exindari MK, Karantas ID, Bikiaris DN. Siafaka PI, et al. Among authors: karantas id. Carbohydr Polym. 2016 Jun 5;143:90-9. doi: 10.1016/j.carbpol.2016.02.009. Epub 2016 Feb 4. Carbohydr Polym. 2016. PMID: 27083347

3

Hypertension in 2017: Update in Treatment and Pharmaceutical Innovations.

Okur ME, Karantas ID, Okur NU, Siafaka PI. Okur ME, et al. Among authors: karantas id. Curr Pharm Des. 2017;23(44):6795-6814. doi: 10.2174/1381612823666170927123454. Curr Pharm Des. 2017. PMID: 28969533 Review.

4

Schizophrenia; A Review on Promising Drug Delivery Systems.

Bülbül EÖ, Karantas ID, Okur ME, Siafaka PI, Okur NÜ. Bülbül EÖ, et al. Among authors: karantas id. Curr Pharm Des. 2020;26(31):3871-3883. doi: 10.2174/1381612826666200523173102. Curr Pharm Des. 2020. PMID: 32445441 Review.

5

Transdermal Drug Delivery Systems and their Potential in Alzheimer's Disease Management.

Siafaka PI, Bülbül EÖ, Mutlu G, Okur ME, Karantas ID, Okur NÜ. Siafaka PI, et al. Among authors: karantas id. CNS Neurol Disord Drug Targets. 2020;19(5):360-373. doi: 10.2174/1871527319666200618150046. CNS Neurol Disord Drug Targets. 2020. PMID: 32552655 Review.

6

Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives.

Karantas ID, Okur ME, Okur NÜ, Siafaka PI. Karantas ID, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(5):815-834. doi: 10.2174/1871530320666200810144004. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32778041 Review.

7

Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications.

Siafaka PI, Özcan Bülbül E, Dilsiz P, Karantas ID, Okur ME, Üstündağ Okur N. Siafaka PI, et al. Among authors: karantas id. J Drug Target. 2021 Jun;29(5):476-490. doi: 10.1080/1061186X.2020.1859516. Epub 2021 Jan 5. J Drug Target. 2021. PMID: 33269637 Review.

8

Recent trends on wound management: New therapeutic choices based on polymeric carriers.

Okur ME, Karantas ID, Şenyiğit Z, Üstündağ Okur N, Siafaka PI. Okur ME, et al. Among authors: karantas id. Asian J Pharm Sci. 2020 Nov;15(6):661-684. doi: 10.1016/j.ajps.2019.11.008. Epub 2020 Jan 23. Asian J Pharm Sci. 2020. PMID: 33363624 Free PMC article. Review.

9

Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.

Siafaka PI, Okur NÜ, Karantas ID, Okur ME, Gündoğdu EA. Siafaka PI, et al. Among authors: karantas id. Asian J Pharm Sci. 2021 Jan;16(1):24-46. doi: 10.1016/j.ajps.2020.03.003. Epub 2020 May 12. Asian J Pharm Sci. 2021. PMID: 33613728 Free PMC article. Review.

10

An Updated Review for the Diabetic Wound Healing Systems.

Okur ME, Bülbül EÖ, Mutlu G, Eleftherıadou K, Karantas ID, Okur NÜ, Siafaka PI. Okur ME, et al. Among authors: karantas id. Curr Drug Targets. 2022;23(4):393-419. doi: 10.2174/1389450122666210914104428. Curr Drug Targets. 2022. PMID: 34521324 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page